Serhat Ünal

Serhat Ünal

Auto-generated profile, based on publicly available information

Serhat Ünal

Hacettepe University Faculty of Medicine, Ankara, Turkiye

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 September 2021 in Journal of Obstetrics and Gynaecology Research
Verified
Journal Article
Open access
PDF file
GAGültekin Adanaş Aydın
Gültekin Adanaş Aydın
SÜSerhat Ünal
Serhat Ünal
HÖHilal Gülsüm Turan Özsoy
Hilal Gülsüm Turan Özsoy
Objective: We aimed to investigate the incidence of adverse pregnancy outcomes including preterm birth, preeclampsia (PE), and fetal growth restriction (FGR) in pregnant women with COVID‐19 according to the gestational age.Methods: This retrospective study included 167 pregnant women who were hospitalized with confirmed COVID‐19. The patients were divided into three groups according to the time of diagnosis as follows: 24 weeks of gestation (n = 129). Medical records of the patients were reviewed retrospectively and adverse pregnancy outcomes were analyzed.Results: A total of 49 (29.3%) patients had an active COVID‐19 infection at the time of delivery, while 118 (70.7%) gave birth after the infection was cleared. Twenty‐three patients had preterm birth and the gestational age was <34 weeks in only four of these patients. There was no significant difference in the preterm birth, PE, FGR, HELLP syndrome, and gestational diabetes mellitus among the three gestation groups (p = 0.271, 0.394, 0.403, 0.763, and 0.664, respectively). Four (2.39%) patients required intensive care unit stay. Maternal death was seen in only one (0.59%) patient.Conclusion: Our study showed no significant correlation between the gestational age at the time of COVID‐19 infection and the frequency of adverse pregnancy outcomes such as preterm birth, PE, FGR, and gestational diabetes mellitus. However, further studies are needed to draw a firm conclusion on this topic.

7 March 2024 in Turkish Journal of Intensive Care
Verified
Journal Article
Open access
IKİsA Kılıç
İsA Kılıç
HAHandan Ankaralı
Handan Ankaralı
GAGültekin Adanaş Aydın
Gültekin Adanaş Aydın
SÜSerhat Ünal
Serhat Ünal
HÖHilal Gülsüm Turan Özsoy
Hilal Gülsüm Turan Özsoy
Amaç: Bu çalışmada koronavirüs hastalığı-2019 (COVİD-19) tanılı gebe ve postpartum kadınların yoğun bakım ihtiyacını öngörebilecek tahmin modeli oluşturulması amaçlanmıştır. Gereç ve Yöntem: Tek merkezli ve retrospektif olarak planlanan çalışma Nisan 2020 ve Aralık 2021 tarihlerinde COVİD-19 tanılı ve kadın doğum kliniğine kabul edilen 18 yaş üzeri gebe ve postpartum hastalar ile yapıldı. Tahmin modeli oluşturulması için hastaların klinik özellikleri, laboratuvar değerleri ve radyolojik özellikleri kaydedildi. Tahmin için iki farklı çok değişkenli lojistik regresyon modeli ve Naive Bayes sınıflandırma algoritması kullanıldı. Geliştirilen tahmin modellerinin sonuçları nomogram ile özetlendi ve tahmin başarıları alıcı işletim karakteristik (ROC) eğrisi ile değerlendirildi. Bulgular: Çalışmaya 436 gebe ve postpartum hasta dahil edildi. Yoğun bakıma yatırılan 51 hastadan 12’si eksitus oldu. Yoğun bakıma yatış risk faktörlerini belirlemek için oluşturduğumuz üç faklı sınıflama modelinin spesifitelerinin %95’in üzerinde ve sensitivitelerinin sırasıyla %70,6, %86,3 ve %87 olduğu belirlendi. Ayrıca ROC’un altındaki alan değerlerinin modeller için sırasıyla 0,94, 0,941 ve 0,978 olduğu bulundu. Yüksek prokalsitonin seviyesi, ateş, dispne ve orta-ağır radyolojik tutulum varlığının gebe ve postpartum kadınlarda yoğun bakım yatışı ile ilişkili risk faktörleri olarak belirlendi. Sonuç: Geliştirdiğimiz risk modelinin uygulanması kolay ve erken dönemde ağır COVİD-19 hastalık riski taşıyan gebeleri belirlemeye ve önlem alınmasına yardımcı olacağı düşünülmektedir

1 April 2026 in Current HIV Research
Verified
Journal Article
Closed access
PDF file
CHCigdem Ataman Hatipoglu
Cigdem Ataman Hatipoglu
SÜSerhat Ünal
Serhat Ünal
MKMeliha Meriç Koç
Meliha Meriç Koç
FAFigen Kaptan Aydoğmuş
Figen Kaptan Aydoğmuş
YBYasar Bayindir
Yasar Bayindir
SKSami Kınıklı
Sami Kınıklı
Objective: HIV testing procedure in the presence of HIV indicator conditions is considered an effective strategy to identify undiagnosed people living with HIV. We aimed in this study to evaluate HIV testing and diagnosis rates obtained via non-targeted testing in seven hospitals across Turkey, specifically focusing on patients with HIV indicator conditions. Methods: Data from a total of 3,371,188 patients with hospital admissions for various clinical conditions were analyzed in this retrospective multicenter cross-sectional study, which was carried out in seven hospitals within a 6-months period. HIV testing and HIV diagnosis rates were retrospectively evaluated in the overall population and in the subgroups of patients with and without HIV-indicator conditions. Results: Rates of HIV testing and positivity in the overall population of 3,371,188 patients screened across seven hospitals were 8.3% (281,321/3,371,188) and 0.2% (557/281,321), respectively. HIV testing and HIV positivity rates in 19,410 patients with HIV-indicator conditions were 11.5% (2,225/19,410) and 0.4% (9/2,225), respectively. HIV testing and HIV positivity rates in 3,351,778 patients without HIV-ICs were 8.3% (279,096/3,351,778) and 0.2% (548/279,096), respectively. The rate of HIV testing and HIV positivity in patients with HIV-ICs was statistically significantly higher than in the patients without HIV-ICs (p = 0.000 and p = 0.047, respectively). Discussion: Our findings revealed that only 11.5% of patients with HIV-indicating conditions underwent HIV testing, indicating that most patients are not timely diagnosed despite having HIV-indicating conditions, and these patients remain at risk of living with unknown HIV status. The utilization of testing outside the HIV-indicator conditions criteria in 8.3% of cases was also notable. The likelihood of a positive diagnosis rate was at least 2-fold increased when the screening was guided by HIV-indicator conditions. Conclusion: In conclusion, according to the study, HIV testing in patients with HIV-indicator conditions increased the rate of HIV diagnosis, but the rate of requesting testing in the presence of HIV indicator conditions was low. HIV testing practices among physicians in the Turkish healthcare settings should be improved with interventions for an improved awareness of HIVindicator conditions, guided HIV testing, and adopting the related guidelines to appropriately identify undiagnosed HIV cases.

3 September 2025 in Expert Review of Vaccines
Verified
Journal Article
Open access
CYCihan Yesiloglu
Cihan Yesiloglu
BABülent Altun
Bülent Altun
OKOnur Keskin
Onur Keskin
ÖDÖmer Dizdar
Ömer Dizdar
SKSedat Kiraz
Sedat Kiraz
SBselim badur
selim badur
Immunocompromised (IC) patients are at increased risk of herpes zoster (HZ; i.e. shingles) and subsequent complications which can significantly impact quality of life. While current evidence indicates a strong disease presence of HZ in Türkiye, literature on the management of HZ in this population is lacking. We conducted a survey with 6 disease experts from various medical specialties in Türkiye to understand their opinions on the burden of HZ and the challenges faced by IC patients, in order to establish a comprehensive and evidence-based expert consensus. Experts agreed that the burden of HZ is significant among IC patients in Türkiye. However, they identified a need for increased local epidemiological data to better understand the health impact of HZ in Türkiye. Improved dissemination of information regarding HZ to physicians was also highlighted to increase awareness of HZ. Strategies to enhance current practices and increase vaccine coverage should include incorporation of HZ vaccination into official guidelines and recommendations, with full or partial reimbursement for HZ vaccination in IC patients. Setting up official or society-initiated online platforms could also support ongoing collaboration and provide continuously updated guidelines reflecting the latest advances in HZ vaccination and disease management.

1 July 2023 in Journal of the College of Physicians and Surgeons Pakistan
Verified
Journal Article
Open access
SÜSerhat Ünal
Serhat Ünal
IKİsa Kılıç
İsa Kılıç
GAGültekin Adanaş Aydın
Gültekin Adanaş Aydın
HGHilal Gulsum
Hilal Gulsum
TOTuran Ozsoy
Turan Ozsoy
AGAdanas Gültekin
Adanas Gültekin

10 April 2023 in Ege Tıp Bilimleri Dergisi
Verified
Journal Article
Open access
IKİsa Kiliç
İsa Kiliç
GAGültekin Adanaş Aydın
Gültekin Adanaş Aydın
HÖHilal Gülsm Turan Özsoy
Hilal Gülsm Turan Özsoy
SÜSerhat Ünal
Serhat Ünal
Amaç: Bu çalışmada yoğun bakımda yatan COVID-19 tanılı gebe ve lohusalarda mortalite prediksiyon modeli oluşturarak APACHE II, SAPS II ve SOFA skorları ile karşılaştırılması amaçlanmıştır. Gereç ve Yöntem: Hastanemizin COVID-19 yoğun bakım ünitelerine yatan Covid-19 tanısı doğrulanmış gebe ve lohusaların demografik, laboratuvar, radyolojik ve klinik verileri geriye dönük olarak kaydedildi. Bulgular: Çalışmaya dahil edilen 50 hastadan 13’ü kaybedildi. Yaş ortalaması ölen grupta 35.54±4.24 yıl, yaşayan grupta 30.03±4.91 yıl idi (p=0.002). Lojistik regresyon modeli, yaş, lenfopeni, yüksek CRP ve IL-6 düzeylerinin mortalite ile ilişkili olduğunu ortaya koydu. Modelin mortalite (AUC) için prediktif gücü 0.946±0.045 (p